scholarly journals Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non–vitamin K antagonist oral anticoagulants

2018 ◽  
Vol 198 ◽  
pp. 166-168 ◽  
Author(s):  
Kazuo Miyazawa ◽  
Daniele Pastori ◽  
Gregory Y.H. Lip
Keyword(s):  
Atrial Fibrillation ◽  
Renal Function ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Vitamin K Antagonist ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation

2015 ◽  
Vol 79 (2) ◽  
pp. 339-345 ◽  
Author(s):  
Keitaro Senoo ◽  
Yee Cheng Lau ◽  
Mikhail Dzeshka ◽  
Deirdre Lane ◽  
Ken Okumura ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Japanese Patients ◽  
Vitamin K Antagonist ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer in Real World: Meta-Analysis of Retrospective Observational Studies

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Cao B ◽  
Hu X ◽  
Chen M ◽  
Shen M ◽  
Xu L
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Real World ◽  
Observational Studies ◽  
Meta Analysis ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Vitamin K Antagonist ◽  
Efficacy And Safety ◽  
Patients With Cancer

Background: Evidence on the safety and effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation (AF) patients with cancer is rather limited, so we performed this meta-analysis to compare the efficacy and safety of NOACs with vitamin K antagonists (VKAs) in real-world patients with AF and cancer.

Sign in / Sign up

Export Citation Format

Share Document